Helsinn Therapeutics

Helsinn is a fully integrated global biopharmaceutical company. It focuses on improving the lives of cancer patients worldwide and is a leader in cancer supportive care and innovative cancer treatment pipelines. Helsinn, a third-generation family business since 1976, has been committed to enhancing patient lives guided by core values of respect, integrity, and quality. It operates a unique licensing business model with integrated drug development and manufacturing capabilities. Helsinn has a commercial presence in 190 countries and operational subsidiaries in the United States and China. Through its Irish subsidiary, Helsinn Birex Pharmaceuticals Ltd., Helsinn also maintains a fully integrated supply chain and product development.